Skip to main content

Advertisement

SpringerLink
Log in

Maternal Serum Transforming Growth Factor Beta-2 in Preeclampsia and Eclampsia, a Potential Biomarker for the Assessment of Disease Severity and Fetal Outcome

  • Original Article
  • Published:
The Journal of the Society for Gynecologic Investigation: JSGI Aims and scope Submit manuscript

Abstract

Objective

The emerging role of transforming growth factor β in hypertension, kidney disease, and trophoblast differentiation promoted our interest in evaluating the clinical value of assaying maternal serum TGF-β2 levels in pregnancies complicated by preeclampsia and eclampsia. We wished to determine these levels in relation to the severity of the disease, the degree of renal involvement, and fetal outcome.

Methods

A prospective study was carried out in 50 pregnant patients with preeclampsia (PE) and eclampsia and these women were compared to 20 pregnant normotensive controls. Preeclamptic patients were subdivided into 20 cases of mild PE, 20 cases of severe PE, and 10 cases of eclampsia. Maternal serum levels of TGF-β2 were determined in all cases by enzyme immunoassay. Maternal serum creatinine and uric acid were measured, together with an assessment of fetal well being, using the Biophysical Profile Score.

Results

Maternal serum TGF-β2 levels were significantly increased in cases of severe preeclampsia and eclampsia compared to controls. This increase was positively correlated with elevated levels of serum creatinine and uric acid, as well as poor biophysical profile scores (BPS), and low birth weight (LBW).

Conclusion

Measurement of maternal serum TGF-β2 levels in preeclampsia may be a useful biomarker for the assessment of the severity of disease and fetal outcome in PE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hughes EC, ed. Obstetric gynecologic terminology. Philadelphia: Davis, 1972.

    Google Scholar 

  2. Greer IA, Lyall F, Perera T, Boswell F, Macara LM. Increased concentrations of cytokines IL-6 & IL-1 receptor antagonist in plasma of women with preeclampsia: A mechanism of endothelial dysfunction. Obstet Gynecol 1994;84:937–40.

    CAS  PubMed  Google Scholar 

  3. Roberts JM, Taylor RM, Musci JT. Endothelial cell activation as pathogenic factor in preeclampsia. Semin Perinatol 1991 ;15:86–93.

    CAS  PubMed  Google Scholar 

  4. Djurovic S, Schjetlein R, Wisloff F, Hangen G, Husby H, Berg K. Plasma concentrations of Lp(a) lipoprotein and TGFβ1 are altered in preeclampsia. Clin Genet 1997;52:371–6.

    Article  CAS  Google Scholar 

  5. Sharma A, Ziyadeh FN. The emerging role of transforming growth factor-B in kidney disease. Physiology 1994;266:829–42.

    Google Scholar 

  6. Dungy LJ, Siddiqi TA, Khem S. Transforming growth factor β1 expression during placental development. Am J Obstet Gynecol 1991; 165:853–7.

    Article  CAS  Google Scholar 

  7. Caniggia I, Mostachfi H, Winter J, et al. Hypoxia-induced factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFβ3. J Clin Invest 2000; 105:577–87.

    Article  CAS  Google Scholar 

  8. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M, Lye SJ. Inhibition of TGFβ3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999;103:1641–50.

    Article  CAS  Google Scholar 

  9. Caniggia I, Winter J, Lye SJ, Post M. Oxygen and placental development during the first trimester: Implications for the pathophysiology of preeclampsia. Placenta 2000;21:25–30.

    Article  Google Scholar 

  10. Cunningham FG, MacDonald PC, Gant NF, Levens KS, Gilstrop J, eds. William’s obstetrics. Norwalk, Connecticut: Appleton and Lang, 1993:763–818.

    Google Scholar 

  11. Manning FA. Dynamic ultrasound based fetal assessment: The fetal biophysical profile score. Clin Obstet Gynecol 1995;38:26–34.

    Article  CAS  Google Scholar 

  12. Van Snik J. IL-6 an overview. Annu Rev Immunol 1990;8:253–78.

    Article  Google Scholar 

  13. Vince GS, Starkey PM, Ausgulen R, Kwiatkowski D, Redman CWG. IL-6 and the soluble receptors in women with preeclampsia. Br J Obstet Gynaecol 1995;192:205–10.

    Google Scholar 

  14. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia: Autocrine transforming growth factor-β expression determines growth response to angiotensin II. J Clin Invest 1992;90:456–61.

    Article  CAS  Google Scholar 

  15. Wolf G, Muller E, Stahl RAK, Ziyadeh FN. Angiogenin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by TGFβ. J Clin Invest 1993;92:1366–72.

    Article  CAS  Google Scholar 

  16. Border WA, Rouslahti E. Transforming growth factor-P in disease, the dark side of tissue repair. J Clin Invest 1992;90:1–7.

    Article  CAS  Google Scholar 

  17. Stallmach T, Hebisch G, Toller H, et al. Expression pattern of cytokines in the different compartments of the feto-maternal unit under various conditions. Reprod Fertil Devel 1995;7: 1573–80.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, Faculty of Medicine, Cairo University, 21 El-Khalifa El-Maamoun Street, Apt. 701, Roxy Building, Heliopolis, Cairo, Egypt

    Mohamed Shaarawy PhD, FRCPath, Mohamed El Meleigy MD & Khaled Rasheed MD

Authors
  1. Mohamed Shaarawy PhD, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamed El Meleigy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Khaled Rasheed MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shaarawy, M., El Meleigy, M. & Rasheed, K. Maternal Serum Transforming Growth Factor Beta-2 in Preeclampsia and Eclampsia, a Potential Biomarker for the Assessment of Disease Severity and Fetal Outcome. Reprod. Sci. 8, 27–31 (2001). https://doi.org/10.1177/107155760100800105

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/107155760100800105

Key words

Search

Navigation